Literature DB >> 11476449

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.

R Hachem1, C Afif, Z Gokaslan, I Raad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476449     DOI: 10.1007/pl00011286

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections.

Authors:  P Villani; M B Regazzi; F Marubbi; P Viale; L Pagani; F Cristini; B Cadeo; G Carosi; R Bergomi
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.

Authors:  Wolfgang A Krueger; Bernd Kottler; Bernd E Will; Alexandra Heininger; Heinz Guggenberger; Klaus E Unertl
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 3.  Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

Authors:  G M Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 4.  Pharmacological issues of linezolid: an updated critical review.

Authors:  Antonello Di Paolo; Paolo Malacarne; Emanuele Guidotti; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

Review 5.  Linezolid treatment of ventriculoperitoneal shunt infection without implant removal.

Authors:  P Castro; A Soriano; C Escrich; G Villalba; M Sarasa; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

6.  Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.

Authors:  Roger Bayston; Gautham Ullas; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

7.  Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

Authors:  Pavlos Myrianthefs; Sophia L Markantonis; Konstantinos Vlachos; Maria Anagnostaki; Eleni Boutzouka; Dimitris Panidis; Georgios Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

8.  Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.

Authors:  J Majcher-Peszynska; G Haase; M Sass; R Mundkowski; A Pietsch; S Klammt; W Schareck; B Drewelow
Journal:  Eur J Clin Pharmacol       Date:  2008-07-25       Impact factor: 2.953

9.  Intraventricular ciprofloxacin usage in treatment of multidrug-resistant central nervous system infections: report of four cases.

Authors:  Ayşe Karaaslan; Eda Kepenekli Kadayifçi; Ozden Turel; Demet Gedikbaşi Toprak; Ahmet Soysal; Mustafa Bakir
Journal:  Pediatr Rep       Date:  2014-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.